In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

New anticoagulants in atrial fibrillation

ESC webinar

Add to calendar27/02/20130:00 27/02/20130:00 Europe/Paris New anticoagulants in atrial fibrillation European Society of Cardiology contact@escardio.org DD/MM/YYYY
Stroke
Cardiovascular Pharmacology and Pharmacotherapy
Atrial Fibrillation


Participants will learn how to translate theoretical information deriving from recently completed trials of new anticoagulants in atrial fibrillation and from the recently revised 2012 ESC Atrial Fibrillation Guidelines into clinical practice.

Two challenging cases of atrial fibrillation management will be presented. Interactive discussion with the audience will lead the participant to logically choose the best treatment options for the cases. Pros and Cons of the available choices will be discussed.

Raffaele de Caterina and Gregory Lip

Focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation *
Developed with the special contribution of the European Heart Rhythm Association.

 

 

R. De Caterina also suggests:
Anticoagulants in heart disease: current status and perspectives. Eur Heart J 2007;28:880-913.
De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Huber K, Jespersen J, Kristensen SD, Lip GYH, Morais J, Rasmussen LH, Siegbahn A, Verheugt FWA, Weitz JI.
New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task force on Anticoagulants in Heart Disease Position Paper. J Am Coll Cardiol 2012;59:1413-25.
Lip GY, Huber K, Andreotti F, Arnesen H, Airaksinen KJ, Cuisset T, Kirchhof P, Marin F. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting.
Thrombosis and haemostasis 2010;103:13-28.